Molina Plans Growth As Exchange Business Rallies

By Amy Lotven / February 14, 2019 at 5:08 PM
Molina Healthcare CEO Joseph Zubretsky pointed to the exchange business as a significant contributor to the company’s favorable 2018 financial results and expects to see continued growth in the sector. The strong exchange performance is a turnaround as Molina had retreated from the exchange markets after seeing large losses in 2016 but re-entered two states for 2019. Zubretsky says that the marketplace contributed $1.9 billion in premium revenue and “exceptional margins” of 11.4 percent in 2018. He cited several factors...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.